Matthew Ronsheim

Companies

• Innoviva, Inc.Officer Jan 10, 2024 to May 21, 2024¹
• Entasis TherapeuticsOfficer Sep 11, 2020 to Jul 11, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IInnoviva, Inc. INVA40,510 shares³$845.0K at $20.86May 20, 2024
• ETEntasis Therapeutics0 shares⁴Jul 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• May 20, 2024Shares withheld for tax 268 shares at $16.13 of Innoviva, Inc.³
• Mar 5, 2024Granted 12,768 shares at $14.88 of Innoviva, Inc.⁵
• Feb 20, 2024Shares withheld for tax 807 shares at $15.80 of Innoviva, Inc.⁶
• Jan 18, 2024Shares withheld for tax 1,600 shares at $16.05 of Innoviva, Inc.⁷
• Jul 11, 2022Returned to company 150,000 shares of Entasis Therapeutics⁴
• Jul 7, 2022U 17,572 shares at $2.20 of Entasis Therapeutics⁴
• Jan 18, 2022Granted 125,000 shares of Entasis Therapeutics⁸
• Nov 2, 2021Shares withheld for tax 3,669 shares at $2.94 of Entasis Therapeutics⁹
• Oct 19, 2021Sold 3,759 shares at $3.19 of Entasis Therapeutics¹⁰
• Oct 19, 2021Granted 25,000 shares of Entasis Therapeutics¹⁰